NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr | ₹1,231 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,833 Cr |
Mar2023 | ₹1,580 Cr |
Mar2022 | ₹1,383 Cr |
Mar2021 | ₹1,325 Cr |
Mar2020 | ₹1,231 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,833 Cr | 16.00 | |
Mar2023 | ₹1,580 Cr | 14.19 | |
Mar2022 | ₹1,383 Cr | 4.43 | |
Mar2021 | ₹1,325 Cr | 7.62 | |
Mar2020 | ₹1,231 Cr | - |
Compare Total Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,483.5 Cr | -7.9% | 2.8% | 116.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -7.9% |
2.8% |
116.5% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses